Brandon Roberts, Annie Waldman and Pratheek Rebala, illustrations by Sam Green for ProPublica When the Trump administration announced massive cuts to federal health agencies earlier this year, Health ...

A series of panels convened by the Food and Drug Administration is raising concerns that the agency is skirting federal rules ...

Vinay K. Prasad, MD, MPH, a controversial hematologist-oncologist who abruptly left his two leadership roles at FDA last ...

Editorial Note: These were the prepared remarks of Peter-Anthony Pappas, who is the Director of IP Policy for Senator Thom Tillis (R-NC). They were delivered on August 4, 2025, at a Listening ...

Since taking office, President Donald Trump has brusquely removed a number of top officials from their positions, including a ...

Mark Cuban challenges the idea that high drug prices are necessary for R&D, PBMs take away from profits, leaving less for innovation.

Only appointed in May 2025, Prasad replaced Peter Marks, who was ousted after clashing with the new Health Secretary Robert F. Kennedy Jr on several issues related to vaccine policy, vaccine safety ...

Nation World FDA vaccine chief leaving agency after less than 3 months Prasad, a longtime critic of the FDA’s leniency in drug approvals, joined the agency in May.

FDA vaccine chief Dr. Vinay Prasad resigns following controversies over gene therapy approvals, sparking criticism from Trump allies and patient groups ...

Dr. Peter Marks, oversaw a steep rise in approvals for new gene therapies, which aim to treat or prevent disease by replacing or modifying a portion of patients’ genetic code. Prasad has been an ...

A controversial hematologist-oncologist who joined FDA this spring and quickly became its top regulator has left the agency.HHS confirmed the departure of Vinay K. Prasad, MD, MPH, providing the ...